Article
Allergan announced the recipients of the first Allergan Horizon Grant Program. The company will contribute $1 million over 2 years to academic medical institutions to support fellows seeking to develop careers in academic medicine. The awards will fund fellowship programs that conduct clinical research in the diagnosis or pharmacological treatment of glaucoma, corneal, and retinal diseases.
Allergan announced the recipients of the first Allergan Horizon Grant Program. The company will contribute $1 million over 2 years to academic medical institutions to support fellows seeking to develop careers in academic medicine. The awards will fund fellowship programs that conduct clinical research in the diagnosis or pharmacological treatment of glaucoma, corneal, and retinal diseases.
Ten grants were awarded to 13 ophthalmology programs. Three programs will share the $40,000 between two therapeutic areas.
The recipients include:
Cornea
Glaucoma
Retina
For more information, visit Allergan at Booth 2831.